A New Dynamic Response to Therapy Assessment in Postoperative Patients With Low-Risk Differentiated Thyroid Cancer Treated Without Radioactive Iodine

BackgroundTotal thyroidectomy (TT) or lobectomy without radioactive iodine (RAI) is becoming a common management for patients with low-risk differentiated thyroid cancer (DTC). However, the assessment of response to therapy for these patients remains controversial. The aim of this study was to propo...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ping Dong, Li Wang, Liu Xiao, Liu Yang, Rui Huang, Lin Li
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/391d87257a8740f3afd14152d938b2f7
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:391d87257a8740f3afd14152d938b2f7
record_format dspace
spelling oai:doaj.org-article:391d87257a8740f3afd14152d938b2f72021-12-01T13:58:11ZA New Dynamic Response to Therapy Assessment in Postoperative Patients With Low-Risk Differentiated Thyroid Cancer Treated Without Radioactive Iodine2234-943X10.3389/fonc.2021.764258https://doaj.org/article/391d87257a8740f3afd14152d938b2f72021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fonc.2021.764258/fullhttps://doaj.org/toc/2234-943XBackgroundTotal thyroidectomy (TT) or lobectomy without radioactive iodine (RAI) is becoming a common management for patients with low-risk differentiated thyroid cancer (DTC). However, the assessment of response to therapy for these patients remains controversial. The aim of this study was to propose and validate a new dynamic evaluation strategy to assess the response to therapy in patients with low-risk DTC treated with TT or lobectomy but without RAI.MethodsWe performed a retrospective analysis of 543 adult patients with low-risk DTC who underwent TT or lobectomy without RAI therapy. Follow-up consisted of trends of serum thyroglobulin (Tg), anti-thyroglobulin antibody (TgAb) levels and neck ultrasonography (US) were conducted every 6–24 months. Response to therapy assessments were defined as excellent response, biochemical incomplete response, structural incomplete response, and indeterminate response according to the follow-up findings.ResultsAt a median follow-up of 51 months (range 33–66 months), 517 (95%) had excellent response, while the other 26 had either biochemical incomplete response (an increasing trend of suppressed serum Tg levels, n=9; an increasing trend of TgAb levels, n=3) or indeterminate response (a stable or decreasing trend of suppressed serum Tg levels, but a stable positive trend of TgAb levels, n=14). No patients had structural incomplete response or no deaths related to thyroid cancer. The risk of incomplete response was significantly higher in lobectomy than in TT (p<0.001).ConclusionOur study proposed and validated a new dynamic response to therapy assessment depending on trends of suppressed serum Tg, TgAb levels, and neck US findings which could be an appropriate tool for postoperative follow-up in low-risk DTC patients without RAI therapy. Our findings provided further evidence to support no routine recommendation of RAI after surgery in low-risk DTC.Ping DongLi WangLiu XiaoLiu YangRui HuangLin LiFrontiers Media S.A.articledifferentiated thyroid cancerlow-riskresponse to therapy assessmentthyroglobulinneck ultrasonographyNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENFrontiers in Oncology, Vol 11 (2021)
institution DOAJ
collection DOAJ
language EN
topic differentiated thyroid cancer
low-risk
response to therapy assessment
thyroglobulin
neck ultrasonography
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle differentiated thyroid cancer
low-risk
response to therapy assessment
thyroglobulin
neck ultrasonography
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Ping Dong
Li Wang
Liu Xiao
Liu Yang
Rui Huang
Lin Li
A New Dynamic Response to Therapy Assessment in Postoperative Patients With Low-Risk Differentiated Thyroid Cancer Treated Without Radioactive Iodine
description BackgroundTotal thyroidectomy (TT) or lobectomy without radioactive iodine (RAI) is becoming a common management for patients with low-risk differentiated thyroid cancer (DTC). However, the assessment of response to therapy for these patients remains controversial. The aim of this study was to propose and validate a new dynamic evaluation strategy to assess the response to therapy in patients with low-risk DTC treated with TT or lobectomy but without RAI.MethodsWe performed a retrospective analysis of 543 adult patients with low-risk DTC who underwent TT or lobectomy without RAI therapy. Follow-up consisted of trends of serum thyroglobulin (Tg), anti-thyroglobulin antibody (TgAb) levels and neck ultrasonography (US) were conducted every 6–24 months. Response to therapy assessments were defined as excellent response, biochemical incomplete response, structural incomplete response, and indeterminate response according to the follow-up findings.ResultsAt a median follow-up of 51 months (range 33–66 months), 517 (95%) had excellent response, while the other 26 had either biochemical incomplete response (an increasing trend of suppressed serum Tg levels, n=9; an increasing trend of TgAb levels, n=3) or indeterminate response (a stable or decreasing trend of suppressed serum Tg levels, but a stable positive trend of TgAb levels, n=14). No patients had structural incomplete response or no deaths related to thyroid cancer. The risk of incomplete response was significantly higher in lobectomy than in TT (p<0.001).ConclusionOur study proposed and validated a new dynamic response to therapy assessment depending on trends of suppressed serum Tg, TgAb levels, and neck US findings which could be an appropriate tool for postoperative follow-up in low-risk DTC patients without RAI therapy. Our findings provided further evidence to support no routine recommendation of RAI after surgery in low-risk DTC.
format article
author Ping Dong
Li Wang
Liu Xiao
Liu Yang
Rui Huang
Lin Li
author_facet Ping Dong
Li Wang
Liu Xiao
Liu Yang
Rui Huang
Lin Li
author_sort Ping Dong
title A New Dynamic Response to Therapy Assessment in Postoperative Patients With Low-Risk Differentiated Thyroid Cancer Treated Without Radioactive Iodine
title_short A New Dynamic Response to Therapy Assessment in Postoperative Patients With Low-Risk Differentiated Thyroid Cancer Treated Without Radioactive Iodine
title_full A New Dynamic Response to Therapy Assessment in Postoperative Patients With Low-Risk Differentiated Thyroid Cancer Treated Without Radioactive Iodine
title_fullStr A New Dynamic Response to Therapy Assessment in Postoperative Patients With Low-Risk Differentiated Thyroid Cancer Treated Without Radioactive Iodine
title_full_unstemmed A New Dynamic Response to Therapy Assessment in Postoperative Patients With Low-Risk Differentiated Thyroid Cancer Treated Without Radioactive Iodine
title_sort new dynamic response to therapy assessment in postoperative patients with low-risk differentiated thyroid cancer treated without radioactive iodine
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/391d87257a8740f3afd14152d938b2f7
work_keys_str_mv AT pingdong anewdynamicresponsetotherapyassessmentinpostoperativepatientswithlowriskdifferentiatedthyroidcancertreatedwithoutradioactiveiodine
AT liwang anewdynamicresponsetotherapyassessmentinpostoperativepatientswithlowriskdifferentiatedthyroidcancertreatedwithoutradioactiveiodine
AT liuxiao anewdynamicresponsetotherapyassessmentinpostoperativepatientswithlowriskdifferentiatedthyroidcancertreatedwithoutradioactiveiodine
AT liuyang anewdynamicresponsetotherapyassessmentinpostoperativepatientswithlowriskdifferentiatedthyroidcancertreatedwithoutradioactiveiodine
AT ruihuang anewdynamicresponsetotherapyassessmentinpostoperativepatientswithlowriskdifferentiatedthyroidcancertreatedwithoutradioactiveiodine
AT linli anewdynamicresponsetotherapyassessmentinpostoperativepatientswithlowriskdifferentiatedthyroidcancertreatedwithoutradioactiveiodine
AT pingdong newdynamicresponsetotherapyassessmentinpostoperativepatientswithlowriskdifferentiatedthyroidcancertreatedwithoutradioactiveiodine
AT liwang newdynamicresponsetotherapyassessmentinpostoperativepatientswithlowriskdifferentiatedthyroidcancertreatedwithoutradioactiveiodine
AT liuxiao newdynamicresponsetotherapyassessmentinpostoperativepatientswithlowriskdifferentiatedthyroidcancertreatedwithoutradioactiveiodine
AT liuyang newdynamicresponsetotherapyassessmentinpostoperativepatientswithlowriskdifferentiatedthyroidcancertreatedwithoutradioactiveiodine
AT ruihuang newdynamicresponsetotherapyassessmentinpostoperativepatientswithlowriskdifferentiatedthyroidcancertreatedwithoutradioactiveiodine
AT linli newdynamicresponsetotherapyassessmentinpostoperativepatientswithlowriskdifferentiatedthyroidcancertreatedwithoutradioactiveiodine
_version_ 1718405050105069568